- +1 212 698 3603
- nathan.williams@dechert.com
- vCard
-
New York OfficeThree Bryant Park, 1095 Avenue of the Americas, New York, NY, United States of America 10036-6797
Nathan Williams is an associate in Dechert’s product liability and mass torts practice and focuses on complex product liability, mass torts and environmental exposure liability.
Mr. Williams has been involved in various stages of litigation defense, from case development and pretrial proceedings to case resolution. He has experience with the affirmative and defensive aspects of fact and expert discovery, including working up and taking depositions of parties and experts. He has also briefed Daubert and dispositive motions in federal court.
Mr. Williams has defended leading companies in the pharmaceutical and performance materials industries in high-stakes litigations involving claims for personal injury, property damage and medical monitoring.
Mr. Williams is a regular contributor to the product liability and mass torts group’s newsletter, Dechert Re:Torts. He was also recognized as Best Lawyers “Ones to Watch” in 2024 for their Mass Tort Litigation / Class Actions – Defendants and Product Liability Litigation – Defendants categories.
Prior to joining Dechert, Mr. Williams was an associate at Quinn Emanuel Urquhart & Sullivan.
- Saint-Gobain as national and trial counsel in a high-profile environmental toxic tort litigation. Currently defending individual and class action complaints involving medical monitoring and property damages claims in New York, New Hampshire and Vermont.
- Pfizer as national coordinating counsel in the Lipitor MDL, where 3,000+ plaintiffs alleged that a cholesterol-lowering medication caused them to develop Type 2 diabetes. Dechert’s Daubert strategy led to exclusion of plaintiffs’ experts on general causation grounds and the granting of summary judgment in all cases in the MDL. The Fourth Circuit unanimously affirmed. Dechert subsequently obtained a similar victory in California Superior Court after the product was spun off from Pfizer to Viatris.
- PFAS: An Evolving Case Study in Environmental Litigation & Regulation - Lawline Webcast (October 26, 2023)
-
- La Sierra University, B.A., 2005, summa cum laude
- American University, M.A., International Affairs, 2008
- Duke University School of Law, J.D., LL.M. International & Comparative Law, 2014, cum laude, Executive Editor of Duke Law Journal
-
- New York
- United States District Court for the Southern District of New York
- United States District Court for the Northern District of New York